Borealis has developed the Bormed family of dedicated healthcare polyolefins to satisfy demand from the pharmaceutical industry for consistency of quality and appropriateness for healthcare applications.

The Bormed range comprises polypropylene (PP), low-density polyethylene (LDPE) and high-density polyethylene (HDPE) grades precisely tailored for the injection and blow moulding of medical devices as well as pharmaceutical and diagnostics packaging.
A million tonnes per year of plastics are already used by the healthcare industry as a result of the many advantages over traditional materials. The industry can only be effectively served by the development of materials specifically for the healthcare market with clear benefits for end users, the company said.
 “Bormed polyolefins display the complete spectrum of properties and characteristics required by the healthcare market. These range from radiation resistance, transparency and chemical inertness to sterilisability at 121 deg C and high environmental stress cracking resistance (ESCR). These performance features, combined with ease of shaping and processing, open up the broadest range of applications,” a spokesman said.
In medical devices these include single-use syringes, needle hubs and catheters, and the housings of artificial kidneys and inhalers. In pharmaceutical packaging, Bormed materials meet the needs of blow, fill and seal containers such as bottles, bags and ampoules for IV sterile liquids as well as blow and injection-moulded packaging such as bottles, containers and closures, he said.
”The excellent performance of Bormed healthcare-dedicated polypropylene and polyethylene materials brings many benefits to our customers and allows cost effective replacement of traditional materials,” he said.